Lindenwold Advisors INC Invests $308,000 in Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Lindenwold Advisors INC has acquired a new position in Option Care Health, Inc., purchasing 8,826 shares valued at approximately $308,000 during the first quarter.
• Analysts have issued positive ratings for Option Care Health, with Barrington Research setting a target price of $38.00 and several firms upgrading their ratings for the stock.
• The company's recent earnings report showed revenue growth of 15.4%, with earnings per share reported at $0.41, exceeding analysts' expectations of $0.40.

Lindenwold Advisors INC purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 8,826 shares of the company's stock, valued at approximately $308,000.

A number of other large investors have also recently made changes to their positions in OPCH. JPMorgan Chase & Co. boosted its holdings in shares of Option Care Health by 29.6% in the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock worth $35,065,000 after buying an additional 344,875 shares during the last quarter. Norges Bank purchased a new position in Option Care Health during the fourth quarter valued at approximately $60,219,000. New Age Alpha Advisors LLC bought a new stake in shares of Option Care Health during the fourth quarter valued at approximately $148,000. Pictet Asset Management Holding SA raised its position in shares of Option Care Health by 12.8% during the fourth quarter. Pictet Asset Management Holding SA now owns 32,885 shares of the company's stock valued at $763,000 after buying an additional 3,738 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its position in Option Care Health by 121.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 142,441 shares of the company's stock worth $3,305,000 after purchasing an additional 78,240 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a report on Thursday. Barrington Research reissued an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Thursday, July 10th. Finally, JMP Securities raised their price objective on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a report on Thursday. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $35.75.

Option Care Health Price Performance

OPCH stock traded down $1.09 on Friday, reaching $28.26. 1,842,798 shares of the company's stock were exchanged, compared to its average volume of 1,424,414. The stock has a fifty day moving average of $31.04 and a 200-day moving average of $31.98. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The firm has a market cap of $4.59 billion, a PE ratio of 22.61, a P/E/G ratio of 1.79 and a beta of 0.79. The company has a quick ratio of 1.02, a current ratio of 1.52 and a debt-to-equity ratio of 0.81.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same quarter in the prior year, the company earned $0.30 earnings per share. Option Care Health's revenue was up 15.4% compared to the same quarter last year. As a group, equities analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.